Not sure how many keep up with his posts but this one relates to Fonterra. He mentions a key failures in governance over recent years. The relevant bit states:
The second failure was the lack of expertise on the Board to recognise the A1 beta-casein issue which is now going to bedevil Fonterra going forward. There was no-one on the Board who could wrestle with the science and ask the right questions. Relying on ‘management advice’ and management-selected consultants is not good enough.
I like the word "bedevil"
FYI https://keithwoodford.wordpress.com...fonterras-governance-is-not-enough/#more-1441
Keith Woodford latest post
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.56 |
Change
0.030(0.54%) |
Mkt cap ! $4.025B | |||
| Open | High | Low | Value | Volume |
| $5.50 | $5.61 | $5.49 | $7.155M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6277 | $5.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.57 | 11611 | 5 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| A2M (ASX) Chart |